MedTrace Logo

Pericapsular Nerve Group Block Chemical Neurolysis in Advanced Hip Osteoarthritis

NCT06087588 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-01-21

No results posted yet for this study

Summary

PENG neurolysis in advanced osteoarthritis of the hip joint.

Conditions

Interventions

DRUG

0.9%sodium chloride

PENG sham block with 20ml 0,9% normal saline

DRUG

95% ethanol

PENG neurolysis with 2.5ml of 95% ethanol

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Katarzyna Wieczorowska-Tobis, Prof.dr hab · Poznań University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-17
Primary Completion
2025-01-10
Completion
2025-01-14

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06087588 on ClinicalTrials.gov